Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Main focus: Gene editing for the treatment of genetic diseases
Company stage: Pre-clinical
Genome editing tool: Undisclosed
Funding stage: Private
Location: Barcelona, Catalonia, Spain
Integra Therapeutics is a start-up company focused on next-generation gene writing. The technology is based on the CRISPR system, which has been merged with transposase and integrase proteins that have a great capacity for gene transfer. Thus, the system does not depend on viral vectors for transporting the gene-editing components into the cell. The company yet has to disclose the specifics of the technology, as well as its lead therapeutic candidates.